These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3368722)

  • 41. Anti-leprosy vaccines--field trials and future prospects.
    Deo MG
    Indian J Lepr; 1984; 56(4):764-75. PubMed ID: 6442720
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hansen's disease: a new endemic focus in the Piacenza Province? A description of four diagnosed cases by cutaneous biopsy.
    Paties C; Schena C; Piva G; Bassi F; Dei Cas A; Alberici F
    Boll Ist Sieroter Milan; 1986; 65(2):125-30. PubMed ID: 3741637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forms of leprosy and in Mitsuda-negative contacts.
    Convit J; Aranzazu N; Ulrich M; Pinardi ME; Reyes O; Alvarado J
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):415-24. PubMed ID: 6763002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of Hansen's disease using d-cycloserine].
    LANGUILLON J; CLARY J
    Med Trop (Mars); 1959; 19():431-7. PubMed ID: 14414036
    [No Abstract]   [Full Text] [Related]  

  • 45. [Result of studies of immunotherapy of lepromatous leprosy and borderline leprosy].
    Saint-André P; Baquillon G; Ferracci C; Ridel PR
    Acta Leprol; 1981; (84):39-55. PubMed ID: 6797222
    [No Abstract]   [Full Text] [Related]  

  • 46. [Association between antigens of the HLA system and Hansen's disease. Familial studies].
    De La Cruz F; Díaz JW; Goncharonko I
    Rev Cubana Med Trop; 1982; 34(1):26-33. PubMed ID: 6750711
    [No Abstract]   [Full Text] [Related]  

  • 47. Hansen's disease and its pedal manifestations.
    Schilansky MM
    J Am Podiatry Assoc; 1983 Aug; 73(8):389-92. PubMed ID: 6619489
    [No Abstract]   [Full Text] [Related]  

  • 48. Practices for self-care in Hansen's disease: face, hands and feet.
    Lima MCV; Barbosa FR; Santos DCMD; Nascimento RDD; D'Azevedo SSP
    Rev Gaucha Enferm; 2018 Oct; 39():e20180045. PubMed ID: 30365764
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Progress in reaction identification and the clinical aspects of Hansen's neuritis].
    Carayon A
    Acta Leprol; 1986; 4(2):237. PubMed ID: 3551461
    [No Abstract]   [Full Text] [Related]  

  • 50. [Health education in Hansen's disease].
    de Mesquita AP
    Hansenol Int; 1983 Dec; 8(2):148-9. PubMed ID: 6678818
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunotherapy for leprosy.
    Fusaro RM
    Arch Dermatol; 1977 Dec; 113(12):1731. PubMed ID: 23076
    [No Abstract]   [Full Text] [Related]  

  • 52. Neuropathies in Hansen's disease.
    Charosky CB; Gatti JC; Cardama JE
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):576-86. PubMed ID: 6323330
    [No Abstract]   [Full Text] [Related]  

  • 53. [Primary animal lepromin with Hansen's bacilli: attalnment & comparative study with human lepromin].
    BERGEL M
    Sem Med; 1958 Aug; 113(6):271-80 passim. PubMed ID: 13602895
    [No Abstract]   [Full Text] [Related]  

  • 54. [Reactional outbreaks during Hansen's disease with 4-butoxy-4'-dimethylamino-thiocarbanilide (Su-1906)].
    MERKLEN FP; RIOU MV; WESSELY F
    Bull Soc Fr Dermatol Syphiligr; 1960; 67():914-6. PubMed ID: 13769637
    [No Abstract]   [Full Text] [Related]  

  • 55. [Immunosuppression mechanisms in leprosy].
    Bottasso OA; Morini JC
    Medicina (B Aires); 1983; 43(5):566-74. PubMed ID: 6371439
    [No Abstract]   [Full Text] [Related]  

  • 56. Activated suppressor T cells in leprosy.
    Mehra V; Convit J; Rubinstein A; Bloom BR
    J Immunol; 1982 Nov; 129(5):1946-51. PubMed ID: 6214583
    [No Abstract]   [Full Text] [Related]  

  • 57. [The etiopathogenetic theory of Hansen's disease "N-Factor/Hansen anergic fringe" on its 50th anniversary: general acceptance--with new authorship and exclusion of the Brazilian origin].
    Rotberg A
    Rev Saude Publica; 1989 Apr; 23(2):175-6. PubMed ID: 2617109
    [No Abstract]   [Full Text] [Related]  

  • 58. Immunotherapy in leprosy.
    Fusaro RM
    JAMA; 1982 Dec; 248(21):2833. PubMed ID: 7143640
    [No Abstract]   [Full Text] [Related]  

  • 59. [Hansen's disease and blood groups in Córdoba (Argentina)].
    Tello EE; Nahra M
    Rev Fac Cien Med Univ Nac Cordoba; 1978; 36(1-4):29-32. PubMed ID: 551495
    [No Abstract]   [Full Text] [Related]  

  • 60. Transfer factor and lepromatous leprosy.
    N Engl J Med; 1973 Apr; 288(14):740-2. PubMed ID: 4688384
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.